HIMS (Hims & Hers Health) Marketable Securities: $529 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HIMS Hims & Hers Health Inc HIMS
83 GF Score
Price $34.83
GF Value $39.46
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Hims & Hers Health Marketable Securities?

Hims & Hers Health HIMS +1.31% 83 Marketable Securities is $529 Mil as of Mar. 2026. GuruFocus rates HIMS with a GF Score™ of 83/100 and a GF Value™ of $39.46 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Hims & Hers Health's Marketable Securities for the quarter that ended in Mar. 2026 was $529 Mil.

Hims & Hers Health's annual Marketable Securities declined from Dec. 2023 ($124 Mil) to Dec. 2024 ($80 Mil) but then increased from Dec. 2024 ($80 Mil) to Dec. 2025 ($349 Mil).

Hims & Hers Health  (NYSE:HIMS) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Hims & Hers Health Marketable Securities Related Terms

Hims & Hers Health Marketable Securities Historical Data

* Premium members only.

The historical data trend for Hims & Hers Health's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hims & Hers Health Marketable Securities Chart

Hims & Hers Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial 175.49 132.85 124.32 79.67 348.88

Hims & Hers Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.94 20.03 283.97 348.88 528.61
HIMS
83GF Score
Hims & Hers Health Inc HIMS
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hims & Hers Health Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $529 Mil mean?
Hims & Hers Health (HIMS) has a Marketable Securities of $529 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Hims & Hers Health and its competitors.
Is Hims & Hers Health's Marketable Securities too high?
Hims & Hers Health's current Marketable Securities is $529 Mil. Overall, Hims & Hers Health has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hims & Hers Health's Marketable Securities compare to LNTH and LQDA?
Hims & Hers Health's Marketable Securities of $529 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Hims & Hers Health and its competitors. Hims & Hers Health's current Marketable Securities is $529 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hims & Hers Health stock overvalued right now?
Based on GuruFocus' analysis, Hims & Hers Health (HIMS) is currently considered Modestly Undervalued. The stock's GF Value™ is $39.46, compared to a current price of $34.83 — trading 11.7% below its estimated fair value. The current Marketable Securities is $529 Mil. Hims & Hers Health's overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Hims & Hers Health (HIMS), the current Marketable Securities is $529 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hims & Hers Health (HIMS) Overvalued in 2026?

Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued. The current stock price of $34.83 is trading 11.7% below its estimated GF Value™ of $39.46. GuruFocus considers Hims & Hers Health to be Modestly Undervalued.

Key valuation signals for HIMS:

  • Marketable Securities: $529 Mil
  • GF Value™: $39.46 vs. price of $34.83 (11.7% below fair value)
  • GF Score™: 83/100 with 3 warning signs

No single metric tells the full story. See the HIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hims & Hers Health Business Description

Other Exchanges HIMS:Mexico82W:Germany
Address 2269 Chestnut Street, No. 523, San Francisco, CA, USA, 94123
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
83GF Score

Get the complete analysis for HIMS

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$34.83
Price
$39.46
GF Value